Presentations from AES and PROMs Summer 2018

OHE staff recently attended AES and PROMs Summer 2018 conferences. In this blog post, we share a selection of our presentations.

OHE staff recently attended AES and PROMs summer 2018 conferences. In this blog post, we share a selection of our presentations.

AES

R&D, Competition and Diffusion of Innovation in EU: The Case of Direct Acting Antivirals (DAAs) for Hepatitis C from Office of Health Economics

Do EQ-5D-3L and EQ-5D-5L Capture the Same Changes in Quality of Life Over Time? A Longitudinal Study of Cancer Patients. from Office of Health Economics

Estimating the Effect of Personal Experience and Vicarious Experience on Time Trade-Off Valuations of Health States. from Office of Health Economics

PROMs

Valuing the EQ-5D-Y Using a Discrete Choice Experiment: Do Adult and Adolescent Preferences Differ? from Office of Health Economics

What Outcomes Matter in Cancer? A Literature Review from Office of Health Economics

Research
Economics of Innovation
Presentations

News & Insights

Latest Research & Publications

Understanding the Full Value of Long-Acting Therapies: less is more?

An Analysis of NICE’s Optimised Decisions from 2015 to 2024

Analysing Global Immunisation Expenditure

The BRAVER Roadmap to Broader Assessment of the Value of Health Interventions in the Asia-Pacific Region

Challenges and Solutions for Budget Impact Analysis of Gene Therapies

The Importance of Diversity of Supply in Rare Diseases Markets

2023 OHE Annual Report to the Charity Commission

Employer Costs from Respiratory Infections

All Publications

Presentations from AES and PROMs Summer 2018

Related News

How do we Get and Pay for New Antibiotics? Proposed New Models for Value Assessment and Contracting for Payment.

Price Transparency: Good or Bad? What Does Literature and Theory Tell Us?

Funding Challenges in the Malaysian Health Care System

OHE at HESG Winter 2020

Share on Mastodon